TAPENTADOL INDUCED HYPOGLYCEMIA: A CASE REPORT

Neha Susan Vinu*, Nikhil M. Sunny and Dr. Joseph John

ABSTRACT

Tapentadol is a centrally acting opioid analgesic with a dual mode of action that combines inhibition of noradrenaline reuptake and agonism of the mu-opioid receptor in one molecule. It is a helpful analgesic for treating acute, chronic, and neuropathic pain because to its dual mechanism of action. Side effects associated with tapentadol are often under reported and further studies and literatures are to be necessitated to establish causality. In this report, we discuss one of the rare adverse effects of Tapentadol-hypoglycemia. The use of Tapentadol as an analgesic have been increasing worldwide for pain relief, hence these life-threatening adverse effects of Tapentadol are to be monitored and borne in mind during its use in any treatment.

Keywords: Tapentadol, Hypoglycemia, Opioids, Pain.